Eli Lilly Sues Canada On Drug Patents

lilly.com

Eli Lilly, a global drug manufacture company in Indiana is suing Canada government and asking to $500 million in damages.

In Lilly’s complaint, they claimed that Canada began using too higher standard of patent to reduce its best seller drugs’ patent period. According to Indystar, Lilly accuses Canadian courts of using “arbitrary and subjective” standards to strip patent protection from Lilly drugs to treat schizophrenia and attention deficit disorder.  

This patent case involves the Lilly drugs Straterra and Zyprexa, which have been used by hundreds of thousands of Canadian patients since the 1990s, Indystar added.

DMC Tower 18th~19th Floor, 189 Sungam-ro, Mapo-gu, Seoul, Korea

Global Tel: +82-2-726-1104, 1130 | Fax: +82-2-777-7334 | global@wips.co.kr

Japan Tel: +82-2-726-1113, 1107 | Fax: +82-2-777-7334 | wips-jp@wips.co.kr

China, Taiwan Tel: +82-2-726-1038, 1130 | Fax: +82-2-777-7334 | global@wips.co.kr